Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Erhan Ararat

TitleAssistant Professor
InstitutionUniversity of Arkansas for Medical Sciences
DepartmentPeds Pediatrics, College of Medicine
DivisionPeds Pulmonary
Address1900 Maryland Street
Mail Slot # 512-17
Little Rock AR 72202
vCardDownload vCard

    Collapse Biography 
    Collapse Leadership and Administrative Roles
    Associate Cystic Fibrosis Center Director


    Collapse Research 
    Collapse research activities and funding
    GR037148     (ARARAT, ERHAN)Jul 1, 2020 - Jun 30, 2021
    UAMS ACHRI Flow Through
    No FP attached
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions. Don't see publications published under other names? Login to add alternative names.
    List All   |   Timeline
    1. Saad D, Ghazala Z, Jesus A, Atteri M, Arundathi R, Ararat E. Preoperative vaping screening in pediatric patients. Pediatr Pulmonol. 2024 Jun; 59(6):1832-1835. PMID: 38506400.
      View in: PubMed
    2. Ghazala Z, Ararat E, Carroll JL, Agarwal A. Volume-targeted ventilation as an invasive home ventilation strategy: A?single-center experience. Pediatr Pulmonol. 2024 Jan; 59(1):203-209. PMID: 37861362.
      View in: PubMed
    3. Ararat E, Landes RD, Forno E, Tas E, Perry TT. Metformin use is associated with decreased asthma exacerbations in adolescents and young adults. Pediatr Pulmonol. 2024 Jan; 59(1):48-54. PMID: 37772681.
      View in: PubMed
    4. Louie SM, Moye AL, Wong IG, Lu E, Shehaj A, Garcia-de-Alba C, Ararat E, Raby BA, Lu B, Paschini M, Bronson RT, Kim CF. Progenitor potential of lung epithelial organoid cells in a transplantation model. Cell Rep. 2022 04 12; 39(2):110662. PMID: 35417699.
      View in: PubMed
    5. Ararat E, Louie SM, Lu E, Paschini M, Raiser DM, Kim CF. Comparison of Transplantation of Lung Organoid Cell Types: One Size Does Not Fit All. Am J Respir Cell Mol Biol. 2022 03; 66(3):340-343. PMID: 35230232.
      View in: PubMed
    6. Ararat E, Sonawalla A, Berlinski A, Tas E. Nutritional status between 5-10 years is associated with cystic fibrosis-related diabetes in adolescence. Pediatr Pulmonol. 2021 10; 56(10):3217-3222. PMID: 34245493.
      View in: PubMed
    7. Sahin I, Ararat E, Sever AR, Altundag K. Early start of adjuvant chemotherapy in breast cancer. J BUON. 2015 Jul-Aug; 20(4):1169. PMID: 26416072.
      View in: PubMed
    8. Birnkrant DJ, Ararat E, Mhanna MJ. Cardiac phenotype determines survival in Duchenne muscular dystrophy. Pediatr Pulmonol. 2016 Jan; 51(1):70-6. PMID: 26097149.
      View in: PubMed
    9. Koca E, Kuzan TY, Dizdar O, Babacan T, Sahin I, Ararat E, Altundag K. Outcomes of locally advanced breast cancer patients with = 10 positive axillary lymph nodes. Med Oncol. 2013; 30(3):615. PMID: 23729267.
      View in: PubMed
    10. Tosur M, Sahin I, Ararat E, Babacan T, Altundag K. Clinical and pathological characteristics of patients 80 years and older with breast cancer. J BUON. 2012 Apr-Jun; 17(2):397-8. PMID: 22740227.
      View in: PubMed
    11. Kizilarslanoglu MC, Aksoy S, Yildirim NO, Ararat E, Sahin I, Altundag K. Temozolomide-related infections: review of the literature. J BUON. 2011 Jul-Sep; 16(3):547-50. PMID: 22006764.
      View in: PubMed
    12. Ararat E, Sahin I, Altundag K. How addition of capecitabine might be more beneficial in the neoadjuvant treatment of breast cancer. J BUON. 2011 Apr-Jun; 16(2):377. PMID: 21766519.
      View in: PubMed
    13. Ararat E, Sahin I, Arslan C, Aksoy S, Dizdar O, Ozisik Y, Altundag K. Clinical and pathological characteristics of very young breast cancer patients (= 25 years of age). J BUON. 2011 Apr-Jun; 16(2):372. PMID: 21766514.
      View in: PubMed
    14. Sahin I, Ararat E, Hashimov A, Altundag K. Sequential taxane and anthracycline-containing neo-adjuvant regimens; any rationale behind the sequence? Breast. 2011 Jun; 20(3):291. PMID: 21371886.
      View in: PubMed
    15. Sahin I, Ararat E, Altundag K. BRCA-deficient and triple negative breast cancers: is olaparib effective in both subtypes? J BUON. 2011 Jan-Mar; 16(1):184-5. PMID: 21674877.
      View in: PubMed
    16. Ararat E, Sahin I, Altundag K. Mechanisms behind the aspirin use and decreased breast cancer incidence. J BUON. 2011 Jan-Mar; 16(1):180. PMID: 21674873.
      View in: PubMed
    17. Sahin I, Ararat E, Altundag K. How can Nolvadex abolish arthralgia in women taking newer generic Tamoxifen preparations? Breast. 2010 Oct; 19(5):436. PMID: 20554203.
      View in: PubMed
    18. Ararat E, Sahin I, Ozdemir E, Altundag K. Mechanisms behind the anti-tumour effects of zoledronic acid use in multiple myeloma. Br J Haematol. 2010 Dec; 151(5):530-1. PMID: 20880117.
      View in: PubMed
    19. Ararat E, Sahin I, Altundag K. Aspirin intake may prevent metastasis in patients with triple-negative breast cancer. Med Oncol. 2011 Dec; 28(4):1308-10. PMID: 20668965.
      View in: PubMed
    20. Sahin I, Ararat E, Altundag K. Possible mechanisms behind taxane-anthracycline sequencing. Lancet Oncol. 2010 Jun; 11(6):514-5. PMID: 20522380.
      View in: PubMed
    21. Ararat E, Brozovich FV. Losartan decreases p42/44 MAPK signaling and preserves LZ+ MYPT1 expression. PLoS One. 2009; 4(4):e5144. PMID: 19357768.
      View in: PubMed
    Ararat's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    See all (104) concept(s)
    _
    Co-Authors Expand Description
    See all (7) people
    _
    Similar People Expand Description
    See all (38) people
    _
    Same Department Expand Description
    Search Department